News
Popular searches: Influenza, Childhood cancer, Endometriosis, Inflammation
-
Ruby Oberin awarded Nancy Millis Bursary
Congratulations to PhD student Ruby Oberin who has been awarded the 2021 Nancy Millis Bursary from Graduate Women Victoria.… Read more
-
Congratulations 2021 SCS 3MT Competition final winners
Congratulations to our PhD students who presented their exceptional research at this year’s SCS Three Minute Thesis (3MT) competition final on Friday, 18 June.… Read more
-
New tool in bowel cancer fight
Drugs that are being trialled to treat leukaemia could also be used to fight bowel cancer after a breakthrough by Hudson Institute of Medical Research scientists.… Read more
-
Students selected for IMNIS mentoring program
Ten Hudson Institute PhD students have been selected for the second year running to participate in the high-level mentoring program, Industry Mentoring Network in STEM (IMNIS).… Read more
-
State-of-the art genomic sequencer accelerates inflammation research
Hudson Institute of Medical Research is progressing its genomic and inflammation research with the acquisition of an Illumina NextSeq 2000, a new sequencing system that provides unprecedented genomic capacity to study inflammatory diseases and microbial diversity.… Read more
-
Rachel’s story: living with Crohn’s disease
Rachel Botros has suffered from Crohn’s disease since she was a 14-year-old. The chronic condition interrupted her schooling and ability to live a typical teenage life. Her two siblings also have the disease. … Read more
-
Scott Johnson Memorial Award for LGBTIQA+ advocacy in STEM
Hudson Institute of Medical Research scientist Dr Erin McGillick has received the national QueersInScience Scott Johnson Memorial Award for contribution to LGBTIQA+ advocacy in STEM.… Read more
-
Osteoporosis research awarded $25,000
The first osteoporosis screening program to identify patients at high risk of fracture following stroke will be established, after the Bone Health Foundation awarded Hudson Institute a $25,000 grant.… Read more
-
Silicosis research awarded more than $1.6 million
Hudson Institute of Medical Research and Monash University have received more than $1.6 million in funding from the Federal Government’s Medical Research Future Fund (MRFF) towards research investigating ways to prevent and treat silicosis.… Read more
-
Ovarian cancer treatment hope
Hudson Institute researchers have shown for the first time that a diabetes drug called sitagliptin can limit tumour growth, and possibly extend survival rates from epithelial ovarian cancer, the most common and dangerous type of ovarian cancer.… Read more